TELA Bio (TELA) Other Non-Current Assets (2023 - 2026)
TELA Bio's (TELA) quarterly Other Non-Current Assets came in at $250000.0 in Q1 2026, down 5.66% year-on-year from $265000.0 in Q1 2025, and little changed quarter-over-quarter from $250000.0 in Q4 2025.
TELA Bio (TELA) Other Non-Current Assets (2023 - 2026) Analysis & Trends
TELA Bio's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 5.66% year-over-year to $250000.0 in Q1 2026; TTM through Mar 2026 was $250000.0, a 5.66% decrease from a year earlier, with the FY2025 full-year figure at $250000.0, down 5.66% from the prior year.
- Other Non-Current Assets held at $250000.0 in Q1 2026 per TELA's latest filing, from $250000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $265000.0 in Q4 2023 and bottomed at $250000.0 in Q3 2025.
- The 4-year median for Other Non-Current Assets is $265000.0 (2023), against an average of $260500.0.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2024 and fell 5.66% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $265000.0 in 2023, then changed by 0.0% to $265000.0 in 2024, then fell by 5.66% to $250000.0 in 2025, then changed by 0.0% to $250000.0 in 2026.
- Per Business Quant, the three latest TELA Other Non-Current Assets figures stand at $250000.0 (Q1 2026), $250000.0 (Q4 2025), and $250000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 738.90 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | 2.25 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 285.90 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 828.89 Mn |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | 250,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Sep 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Sep 30, 2024 | 265,000.00 |
| Jun 30, 2024 | 265,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 265,000.00 |